BCIS-1: Balloon Pump-Assisted Coronary Intervention

Elective Use Of An Intra-Aortic Balloon Pump During High-Risk PCI Is Associated With A 34 Percent Reduction In All-Cause Mortality

Abstract:
Positive long-term mortality results from the Balloon Pump-Assisted Coronary Intervention Study (BCIS-1), which evaluated the effect on major complications and mortality of elective use of an intra-aortic balloon pump (IABP) in patients with low ejection fraction undergoing high-risk percutaneous coronary intervention (PCI). Results from 51 months (mean) of follow up showed that elective IABP use during PCI was associated with a 34 percent reduction in all-cause mortality compared to patients who had no planned IABP insertion prior to PCI. The long-term data were presented in an oral session at the American College of Cardiology’s 61st Annual Scientific Session in Chicago.

Download BCIS-1 Results (PDF: 124 KB / 3 Pages)

Download Powerpoint Slides (PPT: 2 MB / 18 Slides)


A Randomized Controlled Trial Sponsored by the British Cardiovascular Intervention Society

Physician roundtable discussion of the BCIS-1 Long-Term Mortality Data.

Manesh R. Patel, MD
Duke Clinical Research Institute

Divaka Perera, MD, MRCP
St. Thomas’ Hospital, King’s College London

Eric R. Bates, MD
University of Michigan Health System

Marc Cohen, MD
Newark Beth Israel Medical Center, Mount Sinai School of Medicine

Resources

Interventional Cardiology

Surgery

Percutaneous Cardiac Assist Devices

Related Links

Contact Us